GDTC · CytoMed Therapeutics Ltd
Market Cap
$10.41M
Shares
11.83M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Diluted EPS
-$0.27
-68.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| USD/shares | -$0.27 | -$0.16 | -$0.29 | — |
| USD/shares | -$0.27 | -$0.16 | -$0.29 | -$0.30 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.